Noetik
noetik.ai
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Noetik builds self-supervised foundation models of tumour biology trained on spatial multi-omic data it generates in its own laboratory. Founded in 2021 in San Francisco, it uses the models to nominate immuno-oncology targets and predict patient response. The company combines wet lab data generation with large-scale machine learning.
News
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
Agenus Inc., a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik' s artificial intelligence-based TARIO-2 model identified spatial tumor microenvironment patterns associated with clinical outcomes from routin
Read more
Report
Perturb-MARS: Reading mouse experiments through a human lens
Multiplexed in-vivo perturbations, interpreted by a foundation model that has only ever seen human tumors.
Read more
Report
TARIO-2: A Whole-Transcriptome Foundation Model from H&E Alone
Spatial transcriptomics may be the richest measurement of a tumor we have. It's also almost never collected. Here's how we get around that.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.